BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 28875848)

  • 1. Polymeric Nanocarriers: A New Horizon for the Effective Management of Breast Cancer.
    Khan I; Kumar H; Mishra G; Gothwal A; Kesharwani P; Gupta U
    Curr Pharm Des; 2017; 23(35):5315-5326. PubMed ID: 28875848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial: Polymeric Nanocarriers as Robust Platforms for Cancer Therapy.
    Elzoghby AO
    Curr Pharm Des; 2017; 23(35):5211-5212. PubMed ID: 29110600
    [No Abstract]   [Full Text] [Related]  

  • 4. Exploring Therapeutic Potential of Nanocarrier Systems Against Breast Cancer.
    Kumar L; Baldi A; Verma S; Utreja P
    Pharm Nanotechnol; 2018; 6(2):94-110. PubMed ID: 29866028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian carcinoma biological nanotherapy: Comparison of the advantages and drawbacks of lipid, polymeric, and hybrid nanoparticles for cisplatin delivery.
    Zhang Y; Zhang P; Zhu T
    Biomed Pharmacother; 2019 Jan; 109():475-483. PubMed ID: 30399584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymeric Micelles: Recent Advancements in the Delivery of Anticancer Drugs.
    Gothwal A; Khan I; Gupta U
    Pharm Res; 2016 Jan; 33(1):18-39. PubMed ID: 26381278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanocarriers for the Effective Treatment of Cervical Cancer: Research Advancements and Patent Analysis.
    Pathak K; Akhtar N
    Recent Pat Drug Deliv Formul; 2018; 12(2):93-109. PubMed ID: 29611489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combinational drug delivery using nanocarriers for breast cancer treatments: A review.
    Olov N; Bagheri-Khoulenjani S; Mirzadeh H
    J Biomed Mater Res A; 2018 Aug; 106(8):2272-2283. PubMed ID: 29577607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanocarriers for anticancer drugs--new trends in nanomedicine.
    Drbohlavova J; Chomoucka J; Adam V; Ryvolova M; Eckschlager T; Hubalek J; Kizek R
    Curr Drug Metab; 2013 Jun; 14(5):547-64. PubMed ID: 23687925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanocarriers for cancer-targeted drug delivery.
    Kumari P; Ghosh B; Biswas S
    J Drug Target; 2016; 24(3):179-91. PubMed ID: 26061298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymeric nanoparticles: potent vectors for vaccine delivery targeting cancer and infectious diseases.
    Bolhassani A; Javanzad S; Saleh T; Hashemi M; Aghasadeghi MR; Sadat SM
    Hum Vaccin Immunother; 2014; 10(2):321-32. PubMed ID: 24128651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in co-delivery systems based on polymeric nanoparticle for cancer treatment.
    Afsharzadeh M; Hashemi M; Mokhtarzadeh A; Abnous K; Ramezani M
    Artif Cells Nanomed Biotechnol; 2018 Sep; 46(6):1095-1110. PubMed ID: 28954547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellulose-based Nanocarriers as Platforms for Cancer Therapy.
    Meng LY; Wang B; Ma MG; Zhu JF
    Curr Pharm Des; 2017; 23(35):5292-5300. PubMed ID: 29086678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor Targeting of Polymeric Nanoparticles Conjugated with Peptides, Saccharides, and Small Molecules for Anticancer Drugs.
    Bayram B; Ozgur A; Tutar L; Tutar Y
    Curr Pharm Des; 2017; 23(35):5349-5357. PubMed ID: 28911307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Injectable Drug-Loaded Nanocarriers for Lung Cancer Treatments.
    Yu HP; Aljuffali IA; Fang JY
    Curr Pharm Des; 2017; 23(3):481-494. PubMed ID: 28292243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active targeting strategies for anticancer drug nanocarriers.
    Basile L; Pignatello R; Passirani C
    Curr Drug Deliv; 2012 May; 9(3):255-68. PubMed ID: 22452402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticulate carriers: an emerging tool for breast cancer therapy.
    Tharkar P; Madani AU; Lasham A; Shelling AN; Al-Kassas R
    J Drug Target; 2015 Feb; 23(2):97-108. PubMed ID: 25230853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendronized Systems for the Delivery of Chemotherapeutics.
    Dockery L; Daniel MC
    Adv Cancer Res; 2018; 139():85-120. PubMed ID: 29941108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives.
    Edis Z; Wang J; Waqas MK; Ijaz M; Ijaz M
    Int J Nanomedicine; 2021; 16():1313-1330. PubMed ID: 33628022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Advances of Nanotechnology in the Diagnosis and Therapy of Triple- Negative Breast Cancer (TNBC).
    Kanugo A; Gautam RK; Kamal MA
    Curr Pharm Biotechnol; 2022; 23(13):1581-1595. PubMed ID: 34967294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.